A052670 Stock Overview
Cheilbio Co., Ltd. produces and sells veterinary products for pig, cattle, chicken, aqua, and other animals in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Cheilbio Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,080.00 |
| 52 Week High | ₩2,605.00 |
| 52 Week Low | ₩1,131.00 |
| Beta | 0.98 |
| 1 Month Change | 0% |
| 3 Month Change | -13.15% |
| 1 Year Change | 59.39% |
| 3 Year Change | -47.01% |
| 5 Year Change | 3.61% |
| Change since IPO | 36.84% |
Recent News & Updates
Shareholder Returns
| A052670 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 0% | 1.4% | -0.8% |
| 1Y | 59.4% | -0.07% | -10.1% |
Return vs Industry: A052670 exceeded the KR Pharmaceuticals industry which returned 7.4% over the past year.
Return vs Market: A052670 exceeded the KR Market which returned 8% over the past year.
Price Volatility
| A052670 volatility | |
|---|---|
| A052670 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A052670 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine A052670's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | n/a | Gwang-Gyeong Shim | www.cheilbio.com |
Cheilbio Co., Ltd. produces and sells veterinary products for pig, cattle, chicken, aqua, and other animals in South Korea. The company is also involved in the farm disease consulting, such as differentiation of disease and detection of pathogen; development and production of ELISA diagnostic kits; and development instant rapid kits. In addition, it offers raw materials for veterinary pharmaceuticals, fermentation and feed additives ingredients, and feed additives.
Cheilbio Co., Ltd. Fundamentals Summary
| A052670 fundamental statistics | |
|---|---|
| Market cap | ₩56.18b |
| Earnings (TTM) | -₩855.58m |
| Revenue (TTM) | ₩12.71b |
4.4x
P/S Ratio-65.7x
P/E RatioIs A052670 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A052670 income statement (TTM) | |
|---|---|
| Revenue | ₩12.71b |
| Cost of Revenue | ₩10.63b |
| Gross Profit | ₩2.09b |
| Other Expenses | ₩2.94b |
| Earnings | -₩855.58m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -31.67 |
| Gross Margin | 16.40% |
| Net Profit Margin | -6.73% |
| Debt/Equity Ratio | 0% |
How did A052670 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/10/16 05:09 |
| End of Day Share Price | 2023/07/20 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cheilbio Co., Ltd. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|